Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. The diagnosis of nonalcoholic steatohepatitis (NASH), the most severe form of NAFLD, is crucial and has prognostic and therapeutic implications. However, currently this diagnosis is based on liver biops...

Descripción completa

Detalles Bibliográficos
Autores principales: Amorim, Viviane Brandão, Parente, Daniella Braz, Paiva, Fernando Fernandes, Oliveira Neto, Jaime Araújo, Miranda, Amanda Almeida, Moreira, Cláudia Cravo, Fernandes, Flávia Ferreira, Campos, Carlos Frederico Ferreira, Leite, Nathalie Carvalho, Perez, Renata de Mello, Rodrigues, Rosana Souza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Prospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522564/
https://www.ncbi.nlm.nih.gov/pubmed/33033571
http://dx.doi.org/10.4254/wjh.v12.i9.661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522564/
https://www.ncbi.nlm.nih.gov/pubmed/33033571
http://dx.doi.org/10.4254/wjh.v12.i9.661

Ejemplares similares